English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Zendy Plus

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Zendy Tools

Zendy Open

Cumulative evidence indicates that myocardium responds to growth or injury by recruitment of stem and/or progenitor cells that participate in repair and regenerative processes. Unequivocal identification of this population has been hampered by lack of reagents or markers specific to the recruited population, leading to controversies regarding the nature of these cells. Use of a transgenic mouse expressing green fluorescent protein driven by the c‐kit promoter allows for unambiguous identification of this cell population. Green fluorescent protein (GFP) driven by the c‐kit promoter labels a fraction of the c‐kit+ cells recognized by antibody labeling for c‐kit protein. Expression of GFP by the c‐kit promoter and accumulation of GFP‐positive cells in the myocardium is relatively high at birth compared with adult and declines between postnatal weeks 1 and 2, which tracks in parallel with expression of c‐kit protein and c‐kit‐positive cells. Acute cardiomyopathic injury by infarction prompts increased expression of both GFP protein and GFP‐labeled cells in the region of infarction relative to remote myocardium. Similar increases were observed for c‐kit protein and cells with a slightly earlier onset and decline relative to the GFP signal. Cells coexpressing GFP, c‐kit, and cardiogenic markers were apparent at 1–2 weeks postinfarction. Cardiac‐resident c‐kit+ cell cultures derived from the transgenic line express GFP that is diminished in parallel with c‐kit by induction of differentiation. The use of genetically engineered mice validates and extends the concept of c‐kit+ cells participating in the response to myocardial injury.  Disclosure of potential conflicts of interest is found at the end of this article.

Evolution of the c‐kit‐Positive Cell Response to Pathological Challenge in the Myocardium